SALMONES CAMANCHACA S A financials
SALMONES CAMANCHACA S A
21380089WO6GDSOQSA65 | Line item | 2023 | 2022 |
|---|---|---|
| Income statement | ||
| Revenue | $353.9M | $373.0M |
| Cost of sales | $315.5M | $294.1M |
| Gross profit | $38.4M | $78.9M |
| Distribution costs | $13.6M | $9.4M |
| Administrative expenses | $10.2M | $9.6M |
| Finance costs | $11.1M | $6.9M |
| Profit before tax | -$8.5M | $60.5M |
| Income tax expense | -$2.5M | $15.8M |
| Profit for the year | -$6.0M | $44.7M |
| — attributable to owners | -$6.0M | $44.7M |
| — attributable to NCI | $0 | $0 |
| Total comprehensive income | -$6.0M | $44.6M |
| Per share | ||
| Basic EPS | $-0.08 | $0.60 |
| Free cash flow / share | $-0.29 | $0.64 |
| Cash flow statement | ||
| Net cash from operating activities | -$907.0K | $76.0M |
| Net cash from investing activities | -$20.2M | -$28.7M |
| Purchase of PP&E (capex) | $20.3M | $28.8M |
| Net cash from financing activities | $24.7M | -$58.0M |
| Dividends paid | $24.3M | $0 |
| Repayments of borrowings | $0 | $58.0M |
| Net change in cash | $3.6M | -$10.7M |
| Balance sheet | ||
| Total assets | $471.8M | $422.6M |
| Non-current assets | $142.5M | $138.6M |
| Property, plant & equipment | $124.6M | $121.6M |
| Current assets | $329.2M | $284.0M |
| Inventories | $89.9M | $58.0M |
| Trade & other receivables | $16.6M | $14.7M |
| Cash & equivalents | $24.3M | $20.8M |
| Total equity | $194.9M | $213.1M |
| — attributable to owners | $194.9M | $213.1M |
| Non-current liabilities | $137.3M | $115.1M |
| Lease liabilities (non-current) | $1.8M | $405.0K |
| Current liabilities | $139.6M | $94.4M |
| Lease liabilities (current) | $441.0K | $370.0K |
| Deferred tax liabilities | $15.3M | $18.7M |
| Derived metrics | ||
| Free cash flow | -$21.2M | $47.2M |
| Net margin | -1.7% | 12.0% |
| Return on equity | -3.1% | 21.0% |
| Cash conversion ratio | 0.15× | 1.70× |
| Capex coverage | -0.04× | 2.64× |
| Other reported items | ||
| Basic Earnings Loss Per Share From Continuing Operations | $-0.08 | $0.60 |
| Comprehensive Income Attributable To Noncontrolling Interests | $0 | $0 |
| Comprehensive Income Attributable To Owners of Parent | -$6.0M | $44.6M |
| Current Biological Assets | $142.3M | $136.1M |
| Current Provisions For Employee Benefits | $2.1M | $1.7M |
| Current Tax Assets Current | $1.3M | $1.8M |
| Current Tax Assets Noncurrent | $5.8M | $5.0M |
| Deferred Tax Assets | $1.2M | $2.1M |
| Dividends Received Classified As Operating Activities | $0 | $2.8M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -$114.0K | -$724.0K |
| Equity and Liabilities | $471.8M | $422.6M |
| Finance Income | $42.0K | $394.0K |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | $141.0K | -$122.0K |
| Gains Losses On Fair Value Adjustment Biological Assets | -$7.9M | $5.7M |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | $10.0K | $1.0K |
| Income Taxes Paid Refund Classified As Operating Activities | $32.0K | $2.0K |
| Increase Decrease In Cash and Cash Equivalents | $3.5M | -$11.4M |
| Intangible Assets Other Than Goodwill | $7.0M | $7.0M |
| Interest Paid Classified As Operating Activities | $8.6M | $6.5M |
| Interest Received Classified As Operating Activities | $38.0K | $36.0K |
| Investment Accounted For Using Equity Method | $3.8M | $2.9M |
| Issue of Equity | — | $6.0K |
| Issued Capital | $139.8M | $139.8M |
| Noncurrent Payables | $165.0K | $157.0K |
| Noncurrent Provisions For Employee Benefits | $902.0K | $945.0K |
| Other Comprehensive Income | -$42.0K | -$142.0K |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | -$70.0K | -$145.0K |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | $38.0K | $4.0K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Before Tax | -$70.0K | -$145.0K |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Before Tax | $38.0K | $4.0K |
| Other Current Financial Assets | $54.0K | $54.0K |
| Other Current Financial Liabilities | $27.7M | $909.0K |
| Other Current Nonfinancial Assets | $17.7M | $9.2M |
| Other Gains Losses | -$5.3M | -$290.0K |
| Other Individually Immaterial Components of Other Comprehensive Income Before Tax | -$32.0K | -$141.0K |
| Other Noncurrent Financial Assets | $27.0K | $27.0K |
| Other Noncurrent Financial Liabilities | $119.0M | $95.0M |
| Other Noncurrent Nonfinancial Assets | $112.0K | $112.0K |
| Other Reserves | $22.0M | $22.1M |
| Other Shortterm Provisions | $8.0M | $9.5M |
| Payments To and On Behalf of Employees | $35.3M | $29.0M |
| Payments To Suppliers For Goods and Services | $335.2M | $349.0M |
| Proceeds From Current Borrowings | $21.0M | $0 |
| Proceeds From Issuing Shares | $0 | $6.0K |
| Proceeds From Noncurrent Borrowings | $28.0M | $0 |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | $64.0K | $141.0K |
| Profit Loss From Continuing Operations | -$6.0M | $44.7M |
| Receipts From Sales of Goods and Rendering of Services | $378.2M | $457.6M |
| Retained Earnings | $30.7M | $48.9M |
| Share of Profit Loss of Associates Accounted For Using Equity Method | $1.0M | $1.7M |
| Share Premium | $2.3M | $2.3M |
| Trade and Other Current Payables To Related Parties | $6.7M | $10.0M |
| Trade and Other Current Receivables Due From Related Parties | $37.1M | $43.4M |
Every line item above is a fact tagged in SALMONES CAMANCHACA S A's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (USD), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.